Logo image of CTRM

CASTOR MARITIME INC (CTRM) Stock Fundamental Analysis

NASDAQ:CTRM - MHY1146L2082 - Common Stock

2.1636 USD
-0.03 (-1.21%)
Last: 8/27/2025, 12:18:19 PM
Fundamental Rating

4

Overall CTRM gets a fundamental rating of 4 out of 10. We evaluated CTRM against 36 industry peers in the Marine Transportation industry. CTRM has an average financial health and profitability rating. CTRM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CTRM was profitable.
In the past year CTRM had a positive cash flow from operations.
CTRM had positive earnings in 4 of the past 5 years.
CTRM had a positive operating cash flow in 4 of the past 5 years.
CTRM Yearly Net Income VS EBIT VS OCF VS FCFCTRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.24%, CTRM is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.93%, CTRM is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
CTRM has a worse Return On Invested Capital (0.16%) than 75.00% of its industry peers.
CTRM had an Average Return On Invested Capital over the past 3 years of 4.08%. This is below the industry average of 8.49%.
Industry RankSector Rank
ROA 4.24%
ROE 5.93%
ROIC 0.16%
ROA(3y)9.69%
ROA(5y)7.09%
ROE(3y)12.95%
ROE(5y)9.46%
ROIC(3y)4.08%
ROIC(5y)4.6%
CTRM Yearly ROA, ROE, ROICCTRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

CTRM's Profit Margin of 51.03% is amongst the best of the industry. CTRM outperforms 88.89% of its industry peers.
CTRM's Profit Margin has improved in the last couple of years.
CTRM has a Operating Margin of 2.26%. This is in the lower half of the industry: CTRM underperforms 69.44% of its industry peers.
CTRM's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 58.78%, CTRM is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
In the last couple of years the Gross Margin of CTRM has grown nicely.
Industry RankSector Rank
OM 2.26%
PM (TTM) 51.03%
GM 58.78%
OM growth 3Y-65.28%
OM growth 5Y-37.53%
PM growth 3Y9%
PM growth 5Y22.86%
GM growth 3Y-7.34%
GM growth 5Y2.08%
CTRM Yearly Profit, Operating, Gross MarginsCTRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTRM is destroying value.
CTRM has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CTRM has been increased compared to 5 years ago.
Compared to 1 year ago, CTRM has an improved debt to assets ratio.
CTRM Yearly Shares OutstandingCTRM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CTRM Yearly Total Debt VS Total AssetsCTRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.83, we must say that CTRM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.83, CTRM perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that CTRM is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.16, CTRM is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACC0.03
WACC5.13%
CTRM Yearly LT Debt VS Equity VS FCFCTRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 3.94 indicates that CTRM has no problem at all paying its short term obligations.
CTRM has a Current ratio of 3.94. This is amongst the best in the industry. CTRM outperforms 88.89% of its industry peers.
CTRM has a Quick Ratio of 3.92. This indicates that CTRM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.92, CTRM belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.94
Quick Ratio 3.92
CTRM Yearly Current Assets VS Current LiabilitesCTRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CTRM have decreased strongly by -49.74% in the last year.
Measured over the past years, CTRM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -53.56% on average per year.
CTRM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.07%.
Measured over the past years, CTRM shows a very strong growth in Revenue. The Revenue has been growing by 61.83% on average per year.
EPS 1Y (TTM)-49.74%
EPS 3Y-43.17%
EPS 5Y-53.56%
EPS Q2Q%-408.82%
Revenue 1Y (TTM)-32.07%
Revenue growth 3Y-13.62%
Revenue growth 5Y61.83%
Sales Q2Q%-38.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTRM Yearly Revenue VS EstimatesCTRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2.40, the valuation of CTRM can be described as very cheap.
Based on the Price/Earnings ratio, CTRM is valued cheaper than 91.67% of the companies in the same industry.
CTRM is valuated cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.4
Fwd PE N/A
CTRM Price Earnings VS Forward Price EarningsCTRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.14
CTRM Per share dataCTRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CTRM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTOR MARITIME INC

NASDAQ:CTRM (8/27/2025, 12:18:19 PM)

2.1636

-0.03 (-1.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)08-04 2025-08-04
Earnings (Next)11-05 2025-11-05
Inst Owners4.24%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.90M
Analysts0
Price TargetN/A
Short Float %0.52%
Short Ratio1.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.26
Dividend Growth(5Y)N/A
DP7.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.4
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF 0.5
P/B 0.04
P/tB 0.04
EV/EBITDA -6.14
EPS(TTM)0.9
EY41.6%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.13
FCFYN/A
OCF(TTM)4.34
OCFY200.53%
SpS6.86
BVpS59.02
TBVpS55.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.24%
ROE 5.93%
ROCE 0.2%
ROIC 0.16%
ROICexc 0.2%
ROICexgc 0.22%
OM 2.26%
PM (TTM) 51.03%
GM 58.78%
FCFM N/A
ROA(3y)9.69%
ROA(5y)7.09%
ROE(3y)12.95%
ROE(5y)9.46%
ROIC(3y)4.08%
ROIC(5y)4.6%
ROICexc(3y)5.13%
ROICexc(5y)5.44%
ROICexgc(3y)5.14%
ROICexgc(5y)5.45%
ROCE(3y)5.16%
ROCE(5y)5.82%
ROICexcg growth 3Y-73.03%
ROICexcg growth 5Y-46.26%
ROICexc growth 3Y-73.62%
ROICexc growth 5Y-46.97%
OM growth 3Y-65.28%
OM growth 5Y-37.53%
PM growth 3Y9%
PM growth 5Y22.86%
GM growth 3Y-7.34%
GM growth 5Y2.08%
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 5.6
Cap/Depr 479.96%
Cap/Sales 108.95%
Interest Coverage 0.47
Cash Conversion 253.53%
Profit Quality N/A
Current Ratio 3.94
Quick Ratio 3.92
Altman-Z 0.83
F-Score4
WACC5.13%
ROIC/WACC0.03
Cap/Depr(3y)296.8%
Cap/Depr(5y)1001.35%
Cap/Sales(3y)53.29%
Cap/Sales(5y)134.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.74%
EPS 3Y-43.17%
EPS 5Y-53.56%
EPS Q2Q%-408.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.07%
Revenue growth 3Y-13.62%
Revenue growth 5Y61.83%
Sales Q2Q%-38.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-90.44%
EBIT growth 3Y-70.01%
EBIT growth 5Y1.09%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-172.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.6%
OCF growth 3Y-11.65%
OCF growth 5Y78.51%